Skip to Content

Aurora Cannabis Inc ACB

Rating as of

Morningstar’s Analysis

Valuation
Currency in USD

Economic Moat

PREMIUM

Capital Allocation

PREMIUM

Signs of Stability in Aurora’s Q4, but Extreme Uncertainty Points to Better Upside Elsewhere

Analyst Note

| Kristoffer Inton |

Aurora Cannabis' fourth-quarter results continued to be weighed down by the COVID-19 pandemic, but some signs of stability have emerged. Canadian recreational cannabis sales were still down a massive 45% from the year-ago quarter, but things are looking better as sequentially sales were up 8%. The medical market continues to help Aurora, helping drive top-line growth and average realized prices higher.

Read Full Analysis

Company Profile

Business Description

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that include Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael '71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.

Contact
500-10355 Jasper Avenue
Edmonton, AB, T5J 1Y6, Canada
T +1 855 279-4652
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Most Recent Earnings Jun 30, 2021
Fiscal Year End Jun 30, 2022
Stock Type
Employees 1,643